カリフォルニア州におけるオピオイド過剰摂取の臨床試験
カリフォルニア州内の拠点で、オピオイド過剰摂取に関する18件の研究が参加者を募集しています。
カリフォルニア州内の都市
公式研究テキスト（英語）
Buprenorphine Implementation at Syringe Service Programs to Reduce Overdoses
- Community Health Project Los Angeles (CHPLA), Los Angeles
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/10/01更新 · NCT07631598A Study of Brenipatide in Participants With Opioid Use Disorder
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Center on Substance Use and Health (CSUH), San Francisco
- UCSF Weill Institute for Neurosciences - Substance Use Disorders Clinic - Mission Bay, San Francisco
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/22更新 · NCT07420283Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
- Clinic Site A (blinded pending tribal approval), Arcata
被験者募集中
18歳以上 · 全性別 · 2026/09/14更新 · NCT06565416Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.
- Highland Hospital Bridge Clinic at Alameda Health System, Oakland
- Outpatient Buprenorphine Induction Clinic, University of California, San Francisco, San Francisco
被験者募集中第4相
18歳〜99歳 · 全性別 · 2026/09/14更新 · NCT06323824A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
- VA Long Beach Healthcare System, Long Beach, CA, Long Beach
- VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto
- San Francisco VA Medical Center, San Francisco, CA, San Francisco
被験者募集中第4相
18歳以上 · 全性別 · 2026/09/10更新 · NCT04375033EMS-Initiated Buprenorphine
- Alameda Health System, Oakland
被験者募集中観察研究
全年齢 · 全性別 · 2026/08/27更新 · NCT07475728Behavioral Safety and Fentanyl Education: BSAFE
- San Francisco Department of Public Health, San Francisco
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/08/18更新 · NCT07219082Identifying Biomarkers Related to Opioid Use and Pain Response Following Traumatic Injury and Surgery
- University of California, San Diego, La Jolla
被験者募集中観察研究
18歳以上 · 全性別 · 2026/07/17更新 · NCT07693270Telehealth vs In-Person Evaluation of Addiction Treatment After Visiting the Emergency Department
- El Centro Regional Medical Center Emergency Department, El Centro
- University of California Davis Emergency Department, Sacramento
- Olive View - UCLA Medical Center Emegency Department, Sylmar
被験者募集中
18歳以上 · 全性別 · 2026/06/29更新 · NCT06961058Using Clinical Decision Support to Provide Social Risk-Informed Care for Opioid Use Disorder in the Emergency Department
- University of California, San Francisco, San Francisco
被験者募集中
18歳以上 · 全性別 · 2026/06/29更新 · NCT06872190Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment
- El Centro Regional Medical Center Emergency Department, El Centro
- University of California Irvine Emergency Department, Irvine
- Marshall Medical Center Emergency Department, Placerville
- 他1件
被験者募集中
14歳以上 · 全性別 · 2026/06/12更新 · NCT07024498Standard Versus High Dose ED-Initiated Buprenorphine Induction
- Highland Hospital, Oakland
- San Leandro Hospital, San Leandro
被験者募集中第3相
18歳〜65歳 · 全性別 · 2026/05/28更新 · NCT06494904Mapping Ibogaine Neural Dynamics in Opioid Use Disorder
- Susan Samueli Integrative Health Institute, University of California, Irvine, Irvine
被験者募集中観察研究
21歳〜70歳 · 全性別 · 2026/05/18更新 · NCT07226570CARES (Comprehensive Analgesic, Recovery, and Education Support) for Surgery Trial
- Stanford University Medical Center, Stanford
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/05/06更新 · NCT06027099Adaptive Interventions for Emergency Department Patients With Opioid Use Disorder
- Arrowhead Regional Medical Center, Colton
被験者募集中
18歳以上 · 全性別 · 2026/02/19更新 · NCT06827288Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
- UCSD Health, La Jolla
被験者募集中第3相
18歳以上 · 全性別 · 2026/02/03更新 · NCT06387290Individualized Adaptive Deep Brain Stimulation in Opioid Use Disorder
- University of California, San Francisco, San Francisco
被験者募集中
22歳〜75歳 · 全性別 · 2025/10/28更新 · NCT07214467Families Left Behind
- San Diego County Medical Examiner Office, San Diego
被験者募集中
18歳以上 · 全性別 · 2025/08/21更新 · NCT06854757ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。